Catalyst Wire Dossier Catalyst Wire Dossier

recombinant Factor VIII

Factor VIII, recombinant · Bayer
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for recombinant Factor VIII, covering 2013-08-07 to 2021-10-27. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A [Phase 3]

See pricing